Photo: Sen. Bernie Sanders (I-Vt.) addresses reporters during a press conference on Thursday, January 25, 2024 to discuss a Senate Health, Education, Labor, and Pensions Committee markup next week to subpoena drug company CEO’s over drug pricing in the U.S.

The CEOs of Johnson & Johnson and Merck have agreed to testify at a Senate hearing in February about prescription drug prices and will not face a subpoena, Sen. Bernie Sanders (I-Vt.) said Friday.

The Senate Health, Education, Labor and Pensions (HELP) Committee hearing will take place on Feb. 8. Johnson & Johnson CEO Joaquin Duato, Merck CEO Robert Davis and Bristol Myers Squibb CEO Chris Boerner will testify.

Read Article >>>